(Reuters) – Smith & Nephew’s shares rose 9% on Thursday after the British medical equipment maker’s half-year profit beat market forecast, helped by a strong performance in its orthopaedics segment.
The shares in the company, which reiterated its annual expectations, rose 9% in early trading to 1,229.5 pence.
Trading profit for the half-year ended on June 29 was up 12.8% to 471 million pounds ($602.50 million). A company-provided consensus showed analysts, on average, expected about 462 million pounds.
($1 = 0.7817 pounds)
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Janane Venkatraman)
Comments